• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症表观基因组——组成部分及其功能关联

The cancer epigenome--components and functional correlates.

作者信息

Ting Angela H, McGarvey Kelly M, Baylin Stephen B

机构信息

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.

出版信息

Genes Dev. 2006 Dec 1;20(23):3215-31. doi: 10.1101/gad.1464906.

DOI:10.1101/gad.1464906
PMID:17158741
Abstract

It is increasingly apparent that cancer development not only depends on genetic alterations but on an abnormal cellular memory, or epigenetic changes, which convey heritable gene expression patterns critical for neoplastic initiation and progression. These aberrant epigenetic mechanisms are manifest in both global changes in chromatin packaging and in localized gene promoter changes that influence the transcription of genes important to the cancer process. An exciting emerging theme is that an understanding of stem cell chromatin control of gene expression, including relationships between histone modifications and DNA methylation, may hold a key to understanding the origins of cancer epigenetic changes. This possibility, coupled with the reversible nature of epigenetics, has enormous significance for the prevention and control of cancer.

摘要

越来越明显的是,癌症的发展不仅取决于基因改变,还取决于异常的细胞记忆或表观遗传变化,这些变化传递了对肿瘤发生和进展至关重要的可遗传基因表达模式。这些异常的表观遗传机制既体现在染色质包装的整体变化中,也体现在影响癌症进程重要基因转录的局部基因启动子变化中。一个令人兴奋的新主题是,了解干细胞对基因表达的染色质控制,包括组蛋白修饰与DNA甲基化之间的关系,可能是理解癌症表观遗传变化起源的关键。这种可能性,再加上表观遗传学的可逆性,对癌症的预防和控制具有巨大意义。

相似文献

1
The cancer epigenome--components and functional correlates.癌症表观基因组——组成部分及其功能关联
Genes Dev. 2006 Dec 1;20(23):3215-31. doi: 10.1101/gad.1464906.
2
Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.表观遗传学的深入探讨:染色质修饰与DNA甲基化之间的双向关系
Biochem Cell Biol. 2006 Aug;84(4):463-76. doi: 10.1139/o06-090.
3
Epigenetic changes in cancer.癌症中的表观遗传变化。
Annu Rev Pathol. 2009;4:229-49. doi: 10.1146/annurev.pathol.3.121806.151442.
4
Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.利用表观基因组控制癌症促进基因表达程序。
Cancer Cell. 2016 Apr 11;29(4):464-476. doi: 10.1016/j.ccell.2016.03.007.
5
Cancer chemoprevention by targeting the epigenome.靶向表观基因组进行癌症化学预防。
Curr Drug Targets. 2011 Dec;12(13):1925-56. doi: 10.2174/138945011798184155.
6
[Epigenome and cancer: new possibilities of cancer prevention and therapy?].[表观基因组与癌症:癌症预防和治疗的新可能性?]
Postepy Biochem. 2005;51(3):244-50.
7
Phenotypic plasticity and the epigenetics of human disease.表型可塑性与人类疾病的表观遗传学
Nature. 2007 May 24;447(7143):433-40. doi: 10.1038/nature05919.
8
Epigenetic regulation of gene expression in cancer: techniques, resources and analysis.癌症中基因表达的表观遗传调控:技术、资源与分析。
Brief Funct Genomics. 2018 Jan 1;17(1):49-63. doi: 10.1093/bfgp/elx018.
9
Deciphering the cancer imprintome.解析癌症印记组学。
Brief Funct Genomics. 2010 Jul;9(4):329-39. doi: 10.1093/bfgp/elq013. Epub 2010 Jun 15.
10
DNA methylation, chromatin inheritance, and cancer.DNA甲基化、染色质遗传与癌症。
Oncogene. 2001 May 28;20(24):3156-65. doi: 10.1038/sj.onc.1204339.

引用本文的文献

1
Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.多梳抑制复合物2(PRC2)通路在癌细胞可塑性和耐药性中的作用。
Funct Integr Genomics. 2025 Mar 6;25(1):53. doi: 10.1007/s10142-025-01563-8.
2
Progress Toward Epigenetic Targeted Therapies for Childhood Cancer.儿童癌症表观遗传靶向治疗的进展
Cancers (Basel). 2024 Dec 12;16(24):4149. doi: 10.3390/cancers16244149.
3
DNA methylation signatures provide novel diagnostic biomarkers and predict responses of immune therapy for breast cancer.
DNA甲基化特征提供了新的诊断生物标志物,并预测乳腺癌免疫治疗的反应。
Front Genet. 2024 Jun 6;15:1403907. doi: 10.3389/fgene.2024.1403907. eCollection 2024.
4
Methylation Status in Canine Splenic Hemangiosarcoma Tissue and Cell-Free DNA.犬脾脏血管肉瘤组织及游离DNA中的甲基化状态
Animals (Basel). 2023 Sep 21;13(18):2987. doi: 10.3390/ani13182987.
5
The Effects of Green Tea Catechins in Hematological Malignancies.绿茶儿茶素在血液系统恶性肿瘤中的作用
Pharmaceuticals (Basel). 2023 Jul 18;16(7):1021. doi: 10.3390/ph16071021.
6
Synthesis and In Vitro Biological Evaluation of -Carborane-Based Di--butylphenol Analogs.基于 -Carborane 的二 - 丁基酚类似物的合成及体外生物学评价。
Molecules. 2023 Jun 4;28(11):4547. doi: 10.3390/molecules28114547.
7
Genome-wide differential DNA methylation analysis of MDA-MB-231 breast cancer cells treated with curcumin derivatives, ST08 and ST09.姜黄素衍生物 ST08 和 ST09 处理的 MDA-MB-231 乳腺癌细胞的全基因组差异 DNA 甲基化分析。
BMC Genomics. 2022 Dec 6;23(1):807. doi: 10.1186/s12864-022-09041-2.
8
Epigenetic Regulation of Cellular Senescence.细胞衰老的表观遗传调控。
Cells. 2022 Feb 15;11(4):672. doi: 10.3390/cells11040672.
9
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia.发现一种一流的可逆性DNMT1选择性抑制剂,在急性髓系白血病中具有更好的耐受性和疗效。
Nat Cancer. 2021 Oct;2(10):1002-1017. Epub 2021 Sep 27.
10
Epigenetic Alterations in Pancreatic Cancer Metastasis.胰腺癌转移中的表观遗传学改变。
Biomolecules. 2021 Jul 22;11(8):1082. doi: 10.3390/biom11081082.